A patient with widespread firm nontender nodules.
作者信息
Wright William A, Salisbury Jon, Wright David, Rider Tom, Corbett Timothy, Potter Victoria, Krishnamurthy Pramila, Basu Tanya
机构信息
King's College Hospital NHS Foundation Trust, London, United Kingdom.
University Hospitals Sussex NHS Foundation Trust, Worthing, West Sussex.
出版信息
JAAD Case Rep. 2023 May 18;37:68-70. doi: 10.1016/j.jdcr.2023.05.010. eCollection 2023 Jul.
Abstract
摘要
相似文献
1
A patient with widespread firm nontender nodules.
JAAD Case Rep. 2023 May 18;37:68-70. doi: 10.1016/j.jdcr.2023.05.010. eCollection 2023 Jul.
2
Localized skin-limited blastic plasmacytoid dendritic cell neoplasm: A subset with possible durable remission without transplantation.
JAAD Case Rep. 2017 Jul 19;3(4):310-315. doi: 10.1016/j.jdcr.2017.03.015. eCollection 2017 Jul.
3
Case Report of Anti-CD123 Chimeric Antigen Receptor T-Cell Therapy Followed by Radiotherapy for a Recurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem Cell Transplantation.
Onco Targets Ther. 2020 Apr 22;13:3425-3430. doi: 10.2147/OTT.S250016. eCollection 2020.
4
An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Am J Dermatopathol. 2011 May;33(3):e31-6. doi: 10.1097/DAD.0b013e3181de9ce0.
5
A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm in a Child Mimicking Lymphoma/Leukemia Cutis.
Dermatopathology (Basel). 2022 Sep 30;9(4):321-326. doi: 10.3390/dermatopathology9040038.
6
[Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
Rinsho Ketsueki. 2018;59(12):2567-2573. doi: 10.11406/rinketsu.59.2567.
7
A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy.
J Oncol Pharm Pract. 2017 Oct;23(7):552-556. doi: 10.1177/1078155216665245. Epub 2016 Aug 24.
8
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.
Haematologica. 2017 Nov;102(11):1861-1868. doi: 10.3324/haematol.2017.169326. Epub 2017 Aug 10.
9
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
Haematologica. 2015 Feb;100(2):223-30. doi: 10.3324/haematol.2014.111740. Epub 2014 Nov 7.
10
Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature: Acknowledgments.
Transl Cancer Res. 2020 Aug;9(8):4988-4998. doi: 10.21037/tcr-19-2882.
本文引用的文献
1
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin.
Leukemia. 2021 Nov;35(11):3299-3303. doi: 10.1038/s41375-021-01228-y. Epub 2021 Apr 8.
2
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.
N Engl J Med. 2019 Apr 25;380(17):1628-1637. doi: 10.1056/NEJMoa1815105.
3
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
Br J Haematol. 2016 Jul;174(2):188-202. doi: 10.1111/bjh.14146. Epub 2016 Jun 5.
4
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm.
Blood. 2015 Jun 4;125(23):3559-62. doi: 10.1182/blood-2015-01-621268. Epub 2015 Apr 27.
5
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.
Haematologica. 2013 Feb;98(2):239-46. doi: 10.3324/haematol.2012.072645. Epub 2012 Oct 12.
Zotero 插件